AlphaMed Pharmaceuticals Corporation, headquartered in Clearwater Florida, is a privately held biotechnology engineering and manufacturing company. Utilizing cutting edge technology coupled with a "new" approach to pharmaceutical development, AlphaMed management team is dedicated to setting a novel standard in the pursuit of medicine.

AlphaMed will seek to develop alpha 1- antitrypsin as both animal and human pharmaceuticals. The Company's unique marketing approach provides the quickest, most efficient road to sales and success. In addition, AlphaMed is poised to market a new topical therapeutic for the treatment of skin diseases in animals, cromolyn sodium. While independent of the AAT technology, this novel therapeutic puts the company in the unusual position of having "mainstream pharmaceutical" company revenues.

For more information concerning Alphamed's exciting history please visit our news section.